Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. pmc.ncbi.nlm.nih.gov › articles › PMC9630799Zinc supplement use and risk of aggressive prostate cancer: a...

   pmc.ncbi.nlm.nih.gov › articles › PMC9630799

   When stratified by dietary zinc intake (< 11 vs. ≥11 mg/day), supplemental zinc of ≥ 101 mg/day or ≥ 15 years were associated with increased risk of lethal and aggressive prostate cancer in both groups, while significant trend tests were seen in high dietary zinc group but not the other (eTable 1).

   • Zinc as a complementary treatment for cancer patients: a ... - PubMed

     The patients treated with zinc were mainly diagnosed with...

2. link.springer.com › article › 10Zinc as a complementary treatment for cancer patients: a...

   link.springer.com › article › 10

   • Αποθηκευμένο αντίγραφο

   26 Ιαν 2021 · With respect to cancer, several in vitro and in vivo studies point to beneficial effects via the immune system by activating macrophages. Zinc modulates oxidative stress and might help to prevent cancer [7]. In case reports, an improvement of the effects of chemotherapy has been described [8].

3. pmc.ncbi.nlm.nih.gov › articles › PMC7476080Zinc dysregulation in cancers and its potential as a therapeutic...

   pmc.ncbi.nlm.nih.gov › articles › PMC7476080

   The transporter-mediated imbalance of intracellular zinc can contribute to the development and progression of cancer, including prostate cancer (A), breast cancer (B), pancreatic cancer (C), esophageal cancer, and metastatic cancers (D).

4. pubmed.ncbi.nlm.nih.gov › 32587956Zinc: The Wonder Drug for the Treatment of Carcinomas

   pubmed.ncbi.nlm.nih.gov › 32587956

   The decrease in zinc is due to the down regulation of the ZIP-family zinc uptake transporter. These cells are as "ZIP-deficient/decreased zinc" malignancies. This provides a target for a chemotherapy that can restore the high zinc levels that will manifest cytotoxic effects in the malignant cells.

5. pubmed.ncbi.nlm.nih.gov › 33496846Zinc as a complementary treatment for cancer patients: a ... -...

   pubmed.ncbi.nlm.nih.gov › 33496846

   The patients treated with zinc were mainly diagnosed with head and neck cancer and underwent chemo-, radio- or concurrent radio-chemotherapy. Interventions included the intake of different amounts of zinc supplements and oral zinc rinses.

6. www.sciencedirect.com › science › articleZinc carnosine: Frontiers advances of supplement for cancer...

   www.sciencedirect.com › science › article

   1 Ιουλ 2022 · Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy

7. link.springer.com › content › pdfZinc as a complementary treatment for cancer patients: a...

   link.springer.com › content › pdf

   The patients treated with zinc were mainly diagnosed with head and neck cancer and underwent chemo-, radio- or concurrent radio-chemotherapy. Interventions included the intake of diferent amounts of zinc supplements and oral zinc rinses.